• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Rakesh K. Jain, PhD


  • Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-Del Castillo C, Duda DG.A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreatic Ductal Adenocarcinoma.Int J Radiat Oncol Biol Phys. 2014 May 24.
  • Naxerova K, Brachtel E, Salk JJ, Seese AM, Power K, Abbasi B, Snuderl M, Chiang S, Kasif S, Jain RK.Hypermutable DNA chronicles the evolution of human colon cancer.Proc Natl Acad Sci U S A. 2014 Apr 21.
  • Jain RK.An indirect way to tame cancer.Sci Am. 2014 Feb;310(2):46-53.
  • Lemon CM, Curtin PN, Somers RC, Greytak AB, Lanning RM, Jain RK, Bawendi MG, Nocera DG.Metabolic tumor profiling with pH, oxygen, and glucose chemosensors on a quantum dot scaffold.Inorg Chem. 2014 Feb 17;53(4):1900-15.
  • Pinho MC, Polaskova P, Kalpathy-Cramer J, Jennings D, Emblem KE, Jain RK, Rosen BR, Wen PY, Sorensen AG, Batchelor TT, Gerstner ER.Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.Oncologist. 2014 Jan;19(1):75-81.
  • Faber AC, Coffee EM, Costa C, Dastur A, Ebi H, Hata AN, Yeo AT, Edelman EJ, Song Y, Tam AT, Boisvert JL, Milano RJ, Roper J, Kodack DP, Jain RK, Corcoran RB, Rivera MN, Ramaswamy S, Hung KE, Benes CH, Engelman JA.mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.Cancer Discovery. 2014 Jan;4(1):42-52.
  • Huang Y, Stylianopoulos T, Duda DG, Fukumura D, Jain RK.Benefits of vascular normalization are dose and time dependent--letter.Cancer Res. 2013 Dec 1;73(23):7144-6.
  • Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK.Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19059-64.
  • Chen Y, Huang Y, Reiberger T, Duyverman AM, Huang P, Samuel R, Hiddingh L, Roberge S, Koppel C, Lauwers GY, Zhu AX, Jain RK, Duda DG.Differential effects of sorafenib on liver versus tumor fibrosis mediated by SDF1α/CXCR4 axis and Gr-1+ myeloid cell infiltration in mice.Hepatology. 2013 Nov 14.
  • Stylianopoulos T, Jain RK.Combining two strategies to improve perfusion and drug delivery in solid tumors.Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18632-7.
  • Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent FW, Duda DG, Stuart K.A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer.Clin Cancer Res. 2013 Nov 11.
  • Chauhan VP, Jain RK.Strategies for advancing cancer nanomedicine.Nat Mater. 2013 Nov;12(11):958-62.
  • Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, Stylianopoulos T, Mousa AS, Han X, Adstamongkonkul P, Popović Z, Huang P, Bawendi MG, Boucher Y, Jain RK.Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.Nat Commun. 2013;4:2516.
  • Emblem KE, Mouridsen K, Bjornerud A, Farrar CT, Jennings D, Borra RJ, Wen PY, Ivy P, Batchelor TT, Rosen BR, Jain RK, Sorensen AG.Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.Nat Med. 2013 Sep;19(9):1178-83.
  • Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M.Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.J Clin Oncol. 2013 Sep 10;31(26):3212-8.
  • Goel S, Gupta N, Walcott BP, Snuderl M, Kesler CT, Kirkpatrick ND, Heishi T, Huang Y, Martin JD, Ager E, Samuel R, Wang S, Yazbek J, Vakoc BJ, Peterson RT, Padera TP, Duda DG, Fukumura D, Jain RK.Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.Journal of the National Cancer Institute. 2013 Aug 21;105(16):1188-201.
  • Thunemann M, Wen L, Hillenbrand M, Vachaviolos A, Feil S, Ott T, Han X, Fukumura D, Jain RK, Russwurm M, de Wit C, Feil R.Transgenic mice for cGMP imaging.Circ Res. 2013 Aug 2;113(4):365-71.
  • Samuel R, Daheron L, Liao S, Vardam T, Kamoun WS, Batista A, Buecker C, Schäfer R, Han X, Au P, Scadden DT, Duda DG, Fukumura D, Jain RK.Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12774-9.
  • Sahani DV, Jiang T, Hayano K, Duda DG, Catalano OA, Ancukiewicz M, Jain RK, Zhu AX.Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.J Hematol Oncol. 2013;6:51.
  • Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK.Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.Neuro Oncology. 2013 Aug;15(8):1079-87.
  • Jain RK, Munn LL, Fukumura D.Measuring interstitial diffusion, convection, and binding parameters in mouse tumors.Cold Spring Harb Protoc. 2013 Jul;2013(7):678-80.
  • Jain RK, Munn LL, Fukumura D.Measuring interstitial pH and pO2 in mouse tumors.Cold Spring Harb Protoc. 2013 Jul;2013(7):675-7.
  • Jain RK, Munn LL, Fukumura D.Measuring leukocyte-endothelial interactions in mice.Cold Spring Harb Protoc. 2013 Jun;2013(6):561-3.
  • Duda DG, Munn LL, Jain RK.Can We Identify Predictive Biomarkers for Antiangiogenic Therapy of Cancer Using Mathematical Modeling?.Journal of the National Cancer Institute. 2013 May 13.
  • Jain RK.Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers.J Clin Oncol. 2013 May 13.
  • Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK.Co-evolution of solid stress and interstitial fluid pressure in tumors during progression: Implications for vascular collapse.Cancer Res. 2013 May 10.
  • Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC.Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology.Cancer Res. 2013 Apr 15;73(8):2412-2417.
  • Jain RK, Munn LL, Fukumura D.Measuring angiogenesis and hemodynamics in mice.Cold Spring Harb Protoc. 2013;2013(4).
  • Zhu AX, Ancukiewicz M, Supko JG, Sahani DV, Blaszkowsky LS, Meyerhardt JA, Abrams TA, McCleary NJ, Bhargava P, Muzikansky A, Sheehan S, Regan E, Vasudev E, Knowles M, Fuchs CS, Ryan DP, Jain RK, Duda DG.Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.Clin Cancer Res. 2013 Mar 15;19(6):1557-66.
  • Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, Mohan N, Chung E, Roberge S, Peterson T, Bais C, Zhelyazkova BH, Yip S, Hasselblatt M, Rossig C, Niemeyer E, Ferrara N, Klagsbrun M, Duda DG, Fukumura D, Xu L, Carmeliet P, Jain RK.Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.Cell. 2013 Feb 28;152(5):1065-76.
  • Huang Y, Goel S, Duda DG, Fukumura D, Jain RK.Vascular normalization as an emerging strategy to enhance cancer immunotherapy.Cancer Res. 2013 Feb 25.
  • Han HS, Martin JD, Lee J, Harris DK, Fukumura D, Jain RK, Bawendi M.Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo.Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1414-9.
  • Jain RK, Munn LL, Fukumura D.Lung window preparation in mice.Cold Spring Harb Protoc. 2013 Jan;2013(1).
  • Jain RK, Munn LL, Fukumura D.Pancreatic tumor preparation in mice.Cold Spring Harb Protoc. 2012 Dec;2012(12).
  • Jain RK, Munn LL, Fukumura D.Liver tumor preparation in mice.Cold Spring Harb Protoc. 2012 Dec;2012(12).
  • Kodack DP, Chung E, Yamashita H, Incio J, Duyverman AM, Song Y, Farrar CT, Huang Y, Ager E, Kamoun W, Goel S, Snuderl M, Lussiez A, Hiddingh L, Mahmood S, Tannous BA, Eichler AF, Fukumura D, Engelman JA, Jain RK.Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3119-27.
  • Jain RK, Munn LL, Fukumura D.Lymphangiography of the mouse ear.Cold Spring Harb Protoc. 2012;2012(11).
  • Jain RK, Munn LL, Fukumura D.Lymphangiography of the mouse tail.Cold Spring Harb Protoc. 2012;2012(11).
  • Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, Santosuosso M, Martin JD, Martin MR, Vianello F, Leblanc P, Munn LL, Huang P, Duda DG, Fukumura D, Jain RK, Poznansky MC.Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17561-6.
  • Liu J, Liao S, Diop-Frimpong B, Chen W, Goel S, Naxerova K, Ancukiewicz M, Boucher Y, Jain RK, Xu L.TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma.Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16618-23.
  • Jain RK, Munn LL, Fukumura D.Mammary fat pad tumor preparation in mice.Cold Spring Harb Protoc. 2012;2012(10).
  • Jain RK, Munn LL, Fukumura D.Mammary fat pad chamber preparation in mice.Cold Spring Harb Protoc. 2012;2012(10).
  • Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, Bardeesy N, Smith BL, Ferrone CR, Hornicek FJ, Boucher Y, Munn LL, Jain RK.Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15101-8.
  • Jain RK, Munn LL, Fukumura D.Corneal pocket assay in rabbits.Cold Spring Harb Protoc. 2012 Sep;2012(9):1017-8.
  • Stylianopoulos T, Soteriou K, Fukumura D, Jain RK.Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model.Ann Biomed Eng. 2012 Aug 2.
  • Jain RK, Munn LL, Fukumura D.Rabbit ear chambers.Cold Spring Harb Protoc. 2012 Jul;2012(7):813-14.
  • Meyerhardt JA, Ancukiewicz M, Abrams TA, Schrag D, Enzinger PC, Chan JA, Kulke MH, Wolpin BM, Goldstein M, Blaszkowsky L, Zhu AX, Elliott M, Regan E, Jain RK, Duda DG.Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.PLoS ONE. 2012;7(6):e38231.
  • Jain RK, Carmeliet P.SnapShot: Tumor angiogenesis.Cell. 2012 Jun 8;149(6):1408-1408.e1.
  • Chauhan VP, Stylianopoulos T, Martin JD, Popović Z, Chen O, Kamoun WS, Bawendi MG, Fukumura D, Jain RK.Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.Nat Nanotechnol. 2012 Jun;7(6):383-8.
  • Liao S, Liu J, Lin P, Shi T, Jain RK, Xu L.TGF-{beta} Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma Models.Clin Cancer Res. 2011 Mar 15;17(6):1415-24.
  • Farrar CT, Kamoun WS, Ley CD, Kim YR, Catana C, Kwon SJ, Rosen BR, Jain RK, Sorensen AG.Sensitivity of MRI Tumor Biomarkers to VEGFR Inhibitor Therapy in an Orthotopic Mouse Glioma Model.PLoS ONE. 2011;6(3):e17228.
  • Zhu AX, Duda DG, Sahani DV, Jain RK.HCC and angiogenesis: possible targets and future directions.Nat Rev Clin Oncol. 2011 Mar 8.
  • Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG, Jain RK.Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation.Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3725-30.
  • Duda DG, Kozin S, Kirkpatrick ND, Xu L, Fukumura D, Jain RK.CXCL12 (SDF1α) - CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anti-Cancer Therapies?.Clin Cancer Res. 2011 Feb 24.
  • Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK.Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2909-14.
  • Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D.Multistage nanoparticle delivery system for deep penetration into tumor tissue.Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2426-31.
  • Baish JW, Stylianopoulos T, Lanning RM, Kamoun WS, Fukumura D, Munn LL, Jain RK.Scaling rules for diffusive drug delivery in tumor and normal tissues.Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1799-803.
  • Huang Y, Snuderl M, Jain RK.Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity.Cancer Cell. 2011 Jan 18;19(1):1-2.
  • Hiratsuka S, Duda DG, Huang Y, Goel S, Sugiyama T, Nagasawa T, Fukumura D, Jain RK.C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells.Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):302-7.
  • di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK.Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.Cancer Res. 2011 Jan 1;71(1):19-28.
  • Van Cutsem E, Lambrechts D, Prenen H, Jain RK, Carmeliet P.Lessons from the adjuvant bevacizumab trial on colon cancer: what next?.J Clin Oncol. 2011 Jan 1;29(1):1-4.
  • Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Jain RK.Malignant cells facilitate lung metastasis by bringing their own soil.Proc Natl Acad Sci U S A. 2010 Nov 22.
  • Stylianopoulos T, Diop-Frimpong B, Munn LL, Jain RK.Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation.Biophys J. 2010 Nov 17;99(10):3119-28.
  • Popović Z, Liu W, Chauhan VP, Lee J, Wong C, Greytak AB, Insin N, Nocera DG, Fukumura D, Jain RK, Bawendi MG.A Nanoparticle Size Series for In Vivo Fluorescence Imaging.Angew Chem Int Ed Engl. 2010 Nov 8;49(46):8649-52.
  • Jain RK, Stylianopoulos T.Delivering nanomedicine to solid tumors.Nat Rev Clin Oncol. 2010 Nov;7(11):653-64.
  • Chauhan A, Jain RK.Biodegradation: gaining insight through proteomics.Biodegradation. 2010 Nov;21(6):861-79.
  • Yoon SS, Duda DG, Karl DL, Kim TM, Kambadakone AR, Chen YL, Rothrock C, Rosenberg AE, Nielsen GP, Kirsch DG, Choy E, Harmon DC, Hornicek FJ, Dreyfuss J, Ancukiewicz M, Sahani DV, Park PJ, Jain RK, Delaney TF.Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas.Int J Radiat Oncol Biol Phys. 2010 Oct 5.
  • Mounzer RH, Svendsen OS, Baluk P, Bergman CM, Padera TP, Wiig H, Jain RK, McDonald DM, Ruddle NH.Lymphotoxin-alpha contributes to lymphangiogenesis.Blood. 2010 Sep 23;116(12):2173-82.
  • Zhu AX, Duda DG, Ancukiewicz M, di Tomaso E, Clark JW, Miksad R, Fuchs CS, Ryan DP, Jain RK.Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: Kinetics and potential biomarker value.Clin Cancer Res. 2010 Sep 15.
  • Gerstner ER, Eichler AF, Plotkin SR, Drappatz J, Doyle CL, Xu L, Duda DG, Wen PY, Jain RK, Batchelor TT.Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.J. Neurooncol. 2010 Sep 7.
  • Stylianopoulos T, Poh MZ, Insin N, Bawendi MG, Fukumura D, Munn LL, Jain RK.Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions.Biophys J. 2010 Sep 8;99(5):1342-9.
  • Willett CG, Duda DG, Ancukiewicz M, Shah M, Czito BG, Bentley R, Poleski M, Fujita H, Lauwers GY, Carroll M, Tyler D, Mantyh C, Shellito P, Chung DC, Clark JW, Jain RK.A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer.Oncologist. 2010;15(8):845-51.
  • Liao S, Padera TP, Jain RK.Notch leads lymphatics and links them to blood vessels.Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1682-3.
  • Kamoun WS, Chae SS, Lacorre DA, Tyrrell JA, Mitre M, Gillissen MA, Fukumura D, Jain RK, Munn LL.Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks.Nat Methods. 2010 Aug;7(8):655-60.
  • Brown E, Munn LL, Fukumura D, Jain RK.In vivo imaging of tumors.Cold Spring Harb Protoc. 2010 Aug;2010(8):pdb.prot5452.
  • Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, Duda DG.Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation.Cancer Res. 2010 Jul 15;70(14):5679-85.
  • Duda DG, Jain RK.Premetastatic Lung "Niche": Is Vascular Endothelial Growth Factor Receptor 1 Activation Required?.Cancer Res. 2010 Jul 15;70(14):5670-3. Review.
  • Chae SS, Kamoun WS, Farrar CT, Kirkpatrick ND, Niemeyer E, de Graaf AM, Sorensen AG, Munn LL, Jain RK, Fukumura D.Angiopoietin-2 Interferes with Anti-VEGFR-2- Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas.Clin Cancer Res. 2010 Jul 15;16(14):3618-27.
  • Duda DG, Willett CG, Ancukiewicz M, di Tomaso E, Shah M, Czito BG, Bentley R, Poleski M, Lauwers GY, Carroll M, Tyler D, Mantyh C, Shellito P, Clark JW, Jain RK.Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.Oncologist. 2010;15(6):577-83.
  • Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK.Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.J Clin Oncol. 2010 Jun 10;28(17):2817-23.
  • Wong HK, Lahdenranta J, Kamoun WS, Chan AW, McClatchey AI, Plotkin SR, Jain RK, di Tomaso E.Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.Cancer Res. 2010 May 1;70(9):3483-93.
  • Gerstner ER, Chen PJ, Wen PY, Jain RK, Batchelor TT, Sorensen G.Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.Neuro Oncology. 2010 May;12(5):466-72.
  • Fukumura D, Duda DG, Munn LL, Jain RK.Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.Microcirculation. 2010 Apr;17(3):206-25. Review.
  • Kim P, Chung E, Yamashita H, Hung KE, Mizoguchi A, Kucherlapati R, Fukumura D, Jain RK, Yun SH.In vivo wide-area cellular imaging by side-view endomicroscopy.Nat Methods. 2010 Apr;7(4):303-5.
  • Farrar CT, Kamoun WS, Ley CD, Kim YR, Kwon SJ, Dai G, Rosen BR, di Tomaso E, Jain RK, Sorensen AG.In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model.Neuro Oncology. 2010 Apr;12(4):341-50.
  • Choi B, Bouma B, Fukumura D, Jain RK.Optical methods in vascular biology and medicine.J Biomed Opt.;15(1):011001.
  • Finn AV, Jain RK.Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization?.JACC Cardiovasc Imaging. 2010 Jan;3(1):41-4.
  • Kirsch DG, Santiago PM, di Tomaso E, Sullivan JM, Hou WS, Dayton T, Jeffords LB, Sodha P, Mercer KL, Cohen R, Takeuchi O, Korsmeyer SJ, Bronson RT, Kim CF, Haigis KM, Jain RK, Jacks T.p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis.Science. 2010 Jan 29;327(5965):593-6.
  • Liu W, Greytak AB, Lee J, Wong CR, Park J, Marshall LF, Jiang W, Curtin PN, Ting AY, Nocera DG, Fukumura D, Jain RK, Bawendi MG.Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand.J Am Chem Soc. 2010 Jan 20;132(2):472-83.
  • Allen PM, Liu W, Chauhan VP, Lee J, Ting AY, Fukumura D, Jain RK, Bawendi MG.InAs(ZnCdS) quantum dots optimized for biological imaging in the near-infrared.J Am Chem Soc. 2010 Jan 20;132(2):470-1.
  • Duda DG, Ancukiewicz M, Jain RK.Biomarkers of antiangiogenic therapy: how do we move from candidate biomarkers to valid biomarkers?.J Clin Oncol. 2010 Jan 10;28(2):183-5.
  • Chung E, Yamashita H, Au P, Tannous BA, Fukumura D, Jain RK.Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.PLoS ONE. 2009;4(12):e8316.
  • Wen PY,Yung WK,Lamborn KR,Norden AD,Cloughesy TF,Abrey LE,Fine HA,Chang SM,Robins HI,Fink K,Deangelis LM,Mehta M,Di Tomaso E,Drappatz J,Kesari S,Ligon KL,Aldape K,Jain RK,Stiles CD,Egorin MJ,Prados MD.Phase II study of imatinib mesylate (Gleevec(R)) for recurrent meningiomas (North American Brain Tumor Consortium Study 01-08).Neuro-oncol. 2009 Dec;11(6):853-60.
  • Xu L, Duda DG, di Tomaso E, Ancukiewicz M, Chung DC, Lauwers GY, Samuel R, Shellito P, Czito BG, Lin PC, Poleski M, Bentley R, Clark JW, Willett CG, Jain RK.Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.Cancer Res. 2009 Oct 15;69(20):7905-10.
  • Vakoc BJ, Lanning RM, Tyrrell JA, Padera TP, Bartlett LA, Stylianopoulos T, Munn LL, Tearney GJ, Fukumura D, Jain RK, Bouma BE.Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.Nat Med. 2009 Oct;15(10):1219-23.
  • Dawson MR, Duda DG, Chae SS, Fukumura D, Jain RK.VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.PLoS ONE. 2009;4(9):e6525.
  • Dawson MR, Duda DG, Fukumura D, Jain RK.VEGFR1-activity-independent metastasis formation.Nature. 2009 Sep 17;461(7262):E4; discussion E5.
  • Zhu AX, Duda DG, Sahani DV, Jain RK.Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.Cancer J.;15(4):263-8. Review.
  • Plotkin SR, Stemmer-Rachamimov AO, Barker FG, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E.Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.N Engl J Med. 2009 Jul 23;361(4):358-67.
  • Chauhan VP, Lanning RM, Diop-Frimpong B, Mok W, Brown EB, Padera TP, Boucher Y, Jain RK.Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo.Biophys J. 2009 Jul 8;97(1):330-6.
  • Sorensen AG,Batchelor TT,Zhang WT,Chen PJ,Yeo P,Wang M,Jennings D,Wen PY,Lahdenranta J,Ancukiewicz M,di Tomaso E,Duda DG,Jain RK.A "Vascular Normalization Index" as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients.Cancer Res. 2009 Jul 1;69(13):5296-300.
  • Kumar AT, Chung E, Raymond SB, van de Water JA, Shah K, Fukumura D, Jain RK, Bacskai BJ, Boas DA.Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast.Opt Lett. 2009 Jul 1;34(13):2066-8.
  • Au P,Tam J,Duda DG,Lin PC,Munn LL,Fukumura D,Jain RK.Paradoxical Effects of PDGF-BB Overexpression in Endothelial Cells on Engineered Blood Vessels In Vivo.Am J Pathol. 2009 Jul;175(1):294-302.
  • Zhu AX,Sahani DV,Duda DG,di Tomaso E,Ancukiewicz M,Catalano OA,Sindhwani V,Blaszkowsky LS,Yoon SS,Lahdenranta J,Bhargava P,Meyerhardt J,Clark JW,Kwak EL,Hezel AF,Miksad R,Abrams TA,Enzinger PC,Fuchs CS,Ryan DP,Jain RK.Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study.J Clin Oncol. 2009 Jun 20;27(18):3027-35.
  • Willett CG,Duda DG,di Tomaso E,Boucher Y,Ancukiewicz M,Sahani DV,Lahdenranta J,Chung DC,Fischman AJ,Lauwers GY,Shellito P,Czito BG,Wong TZ,Paulson E,Poleski M,Vujaskovic Z,Bentley R,Chen HX,Clark JW,Jain RK.Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study.J Clin Oncol. 2009 Jun 20;27(18):3020-6.
  • Chi AS,Sorensen AG,Jain RK,Batchelor TT.Angiogenesis as a Therapeutic Target in Malignant Gliomas.Oncologist. 2009 Jun;14(6):621-36. Review.
  • Jain RK.A new target for tumor therapy.N Engl J Med. 2009 Jun 18;360(25):2669-71.
  • Jain RK,Duda DG,Willett CG,Sahani DV,Zhu AX,Loeffler JS,Batchelor TT,Sorensen AG.Biomarkers of response and resistance to antiangiogenic therapy.Nat Rev Clin Oncol. 2009 Jun;6(6):327-338. Review.
  • di Tomaso E,London N,Fuja D,Logie J,Tyrrell JA,Kamoun W,Munn LL,Jain RK.PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment.PLoS ONE. 2009;4(4):e5123.
  • Gerstner ER,Sorensen AG,Jain RK,Batchelor TT.Anti-vascular endothelial growth factor therapy for malignant glioma.Curr Neurol Neurosci Rep. 2009 May;9(3):254-62. Review.
  • Gerstner ER,Duda DG,di Tomaso E,Ryg PA,Loeffler JS,Sorensen AG,Ivy P,Jain RK,Batchelor TT.VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.Nat Rev Clin Oncol. 2009 Apr;6(4):229-36. Review.
  • Kamoun WS,Ley CD,Farrar CT,Duyverman AM,Lahdenranta J,Lacorre DA,Batchelor TT,di Tomaso E,Duda DG,Munn LL,Fukumura D,Sorensen AG,Jain RK.Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.J Clin Oncol. 2009 May 20;27(15):2542-52.
  • Tam J,Duda DG,Perentes JY,Quadri RS,Fukumura D,Jain RK.Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.PLoS ONE. 2009;4(3):e4974.
  • Mok W,Stylianopoulos T,Boucher Y,Jain RK.Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.Clin Cancer Res. 2009 Apr 1;15(7):2352-60.
  • Lahdenranta J,Hagendoorn J,Padera TP,Hoshida T,Nelson G,Kashiwagi S,Jain RK,Fukumura D.Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.Cancer Res. 2009 Apr 1;69(7):2801-8.
  • Perentes JY,Duda DG,Jain RK.Visualizing anti-tumor immune responses in vivo.Dis Model Mech. 2009 Mar;2(3-4):107-10.
  • Cheng G,Tse J,Jain RK,Munn LL.Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells.PLoS ONE. 2009;4(2):e4632.
  • Luong MX,Tam J,Lin Q,Hagendoorn J,Moore KJ,Padera TP,Seed B,Fukumura D,Kucherlapati R,Jain RK.Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.J Cell Physiol. 2009 May;219(2):430-7.
  • Perentes JY,McKee TD,Ley CD,Mathiew H,Dawson M,Padera TP,Munn LL,Jain RK,Boucher Y.In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts.Nat Methods. 2009 Feb;6(2):143-5.
  • Gerstner ER,Sorensen AG,Jain RK,Batchelor TT.Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas.Curr Opin Neurol. 2008 Dec;21(6):728-35. Review.
  • Fukumura D,Jain RK.Imaging angiogenesis and the microenvironment.APMIS. 2008 Jul-Aug;116(7-8):695-715. Review.
  • Sorensen AG,Batchelor TT,Wen PY,Zhang WT,Jain RK.Response criteria for glioma.Nat Clin Pract Oncol. 2008 Nov;5(11):634-44. Review.
  • Padera TP,Jain RK.VEGFR3: a new target for antiangiogenesis therapy?.Dev Cell. 2008 Aug;15(2):178-9.
  • Padera TP,Kuo AH,Hoshida T,Liao S,Lobo J,Kozak KR,Fukumura D,Jain RK.Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib.Mol Cancer Ther. 2008 Aug;7(8):2272-9.
  • Huang P,Duda DG,Jain RK,Fukumura D.Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.Comp Med. 2008 Jun;58(3):253-63.
  • Nagano S,Perentes JY,Jain RK,Boucher Y.Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors.Cancer Res. 2008 May 15;68(10):3795-802.
  • Jain RK.Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer.Nat Rev Cancer. 2008 Apr;8(4):309-16. Review.
  • Jones RC, Capen DE, Cohen KS, Munn LL, Jain RK, Duda DG.A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents.Nat Protoc. 2008;3(3):388-97.
  • Jones RC, Capen D, Petersen B, Jain RK, Duda DG.A protocol for a lung neovascularization model in rodents.Nat Protoc. 2008;3(3):378-87.
  • Kashiwagi S, Tsukada K, Xu L, Miyazaki J, Kozin SV, Tyrrell JA, Sessa WC, Gerweck LE, Jain RK, Fukumura D.Perivascular nitric oxide gradients normalize tumor vasculature.Nat Med. 2008 Mar;14(3):255-7.
  • Au P, Tam J, Fukumura D, Jain RK.Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature.Blood. 2008 May 1;111(9):4551-8.
  • Jain RK, Lahdenranta J, Fukumura D.Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model.PLoS Med. 2008 Jan 29;5(1):e24.
  • Jain RK.Taming vessels to treat cancer.Sci Am. 2008 Jan;298(1):56-63.
  • Nelson GM, Padera TP, Garkavtsev I, Shioda T, Jain RK.Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells.Neoplasia. 2007 Dec;9(12):1038-45.
  • Gerstner ER, Duda DG, di Tomaso E, Sorensen G, Jain RK, Batchelor TT.Antiangiogenic agents for the treatment of glioblastoma.Expert Opin Investig Drugs. 2007 Dec;16(12):1895-908. Review.
  • Mok W, Boucher Y, Jain RK.Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus.Cancer Res. 2007 Nov 15;67(22):10664-8.
  • Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK.Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.Blood. 2008 Feb 1;111(3):1302-5.
  • Jain RK, Xu L.alphaPlGF: a new kid on the antiangiogenesis block.Cell. 2007 Nov 2;131(3):443-5.
  • Willett CG, Duda DG, Czito BG, Bendell JC, Clark JW, Jain RK.Targeted therapy in rectal cancer.Oncology (Huntingt). 2007 Aug;21(9):1055-65; discussion 1065,. Review.
  • Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT.Angiogenesis in brain tumours.Nat Rev Neurosci. 2007 Aug;8(8):610-22. Review.
  • Duda DG, Batchelor TT, Willett CG, Jain RK.VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.Trends Mol Med. 2007 Jun;13(6):223-30.
  • Padera TP, Ancukiewicz M, Hoshida T, Fukumura D, Jain RK.Data Do Not Support Benefits of Anti-VEGFR3 Therapy.Cancer Res. 2007 May 15;67(10):5055.
  • Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK.Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.Nat Clin Pract Oncol. 2007 May;4(5):316-21.
  • Duda DG, Cohen KS, Scadden DT, Jain RK.A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood.Nat Protoc. 2007;2(4):805-10.
  • Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, Arzigian M, Fukumura D, Jain RK, Scadden DT.Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo.Nat Biotechnol. 2007 Mar;25(3):317-8.
  • Lawenda BD, Smith DE, Xu L, Niemierko A, Silverstein JR, Boucher Y, Kashiwagi S, Held KD, Jain RK, Loeffler JS, Eisenberg DM, Blumberg JB.Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.J Soc Integr Oncol. 2007 Winter;5(1):11-7.
  • Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK.AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.Cancer Cell. 2007 Jan;11(1):83-95.
  • Willett CG, Kozin SV, Duda DG, di Tomaso E, Kozak KR, Boucher Y, Jain RK.Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice.Semin Oncol. 2006 Oct;33(5 Suppl 10):S35-40. Review.
  • Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK, Fukumura D.Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models.Cancer Res. 2006 Apr 15;66(8):3971-7.
  • Duda DG, Cohen KS, di Tomaso E, Au P, Klein RJ, Scadden DT, Willett CG, Jain RK.Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.J Clin Oncol. 2006 Mar 20;24(9):1449-53.
  • McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi MG, Boucher Y, Breakefield XO, Jain RK.Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.Cancer Res. 2006 Mar 1;66(5):2509-13.
  • Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, Wagner DD.Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60.
  • Jain RK, Duda DG, Clark JW, Loeffler JS.Lessons from phase III clinical trials on anti-VEGF therapy for cancer.Nat Clin Pract Oncol. 2006 Jan;3(1):24-40. Review.
  • Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, Jain RK.Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.Blood. 2006 Apr 1;107(7):2774-6.
  • Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY.Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.J Clin Oncol. 2005 Nov 1;23(31):8136-9.
  • Ny A, Koch M, Schneider M, Neven E, Tong RT, Maity S, Fischer C, Plaisance S, Lambrechts D, Heligon C, Terclavers S, Ciesiolka M, Kalin R, Man WY, Senn I, Wyns S, Lupu F, Brandli A, Vleminckx K, Collen D, Dewerchin M, Conway EM, Moons L, Jain RK, Carmeliet P.A genetic Xenopus laevis tadpole model to study lymphangiogenesis.Nat Med. 2005 Sep;11(9):998-1004.
  • Acker T, Diez-Juan A, Aragones J, Tjwa M, Brusselmans K, Moons L, Fukumura D, Moreno-Murciano MP, Herbert JM, Burger A, Riedel J, Elvert G, Flamme I, Maxwell PH, Collen D, Dewerchin M, Jain RK, Plate KH, Carmeliet P.Genetic evidence for a tumor suppressor role of HIF-2alpha.Cancer Cell. 2005 Aug;8(2):131-41.
  • Demou ZN, Awad M, McKee T, Perentes JY, Wang X, Munn LL, Jain RK, Boucher Y.Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.Cancer Res. 2005 Jul 1;65(13):5674-82.
  • di Tomaso E, Capen D, Haskell A, Hart J, Logie JJ, Jain RK, McDonald DM, Jones R, Munn LL.Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.Cancer Res. 2005 Jul 1;65(13):5740-9.
  • Xu L, Tong R, Cochran DM, Jain RK.Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.Cancer Res. 2005 Jul 1;65(13):5711-9.
  • Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D.NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.J Clin Invest. 2005 Jul;115(7):1816-27.
  • Jain RK.Antiangiogenic therapy for cancer: current and emerging concepts.Oncology (Huntingt). 2005 Apr;19(4 Suppl 3):7-16.
  • Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, Jain RK.Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.Nat Med. 2005 Jun;11(6):678-82.
  • Sun J, Wang DA, Jain RK, Carie A, Paquette S, Ennis E, Blaskovich MA, Baldini L, Coppola D, Hamilton AD, Sebti SM.Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors.Oncogene. 2005 Jul 7;24(29):4701-9.
  • Jain RK.Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.Science. 2005 Jan 7;307(5706):58-62.
  • Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK.Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.Cancer Cell. 2004 Dec;6(6):553-63.
  • Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.Nat Med. 2004 Feb;10(2):145-7.
  • Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher Y, Jain RK.Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation.Nat Med. 2003 Jun;9(6):796-800.
  • Jain RK, Munn LL, Fukumura D.Dissecting tumour pathophysiology using intravital microscopy.Nat Rev Cancer. 2002 Apr;2(4):266-76.
  • Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK.Lymphatic metastasis in the absence of functional intratumor lymphatics.Science. 2002 Jun 7;296(5574):1883-6.
  • Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK.Tumour biology: herceptin acts as an anti-angiogenic cocktail.Nature. 2002 Mar 21;416(6878):279-80.
  • Jain RK.Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.Nat Med. 2001 Sep;7(9):987-9.